CircuLite Announces Four Presentations at Transcatheter Cardiovascular Therapeutics Conference

SADDLE BROOK, N.J.--(BUSINESS WIRE)--CircuLite®, Inc. today announced its SYNERGY® Circulatory Support System will be included in four presentations at the 24th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation, which is being held October 22-26, 2012 in Miami. CircuLite recently announced CE Marking approval for the SYNERGY® System, which is a micro-pump designed to halt the progression of heart failure and to improve symptoms and exercise tolerance. By working with the heart’s native pumping capacity, the SYNERGY System is specifically targeted for treatment of ambulatory heart failure patients (INTERMACS 4,5,6 / NYHA III and early IV) who remain symptomatic despite standard medical management.
MORE ON THIS TOPIC